Your browser doesn't support javascript.
loading
Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung Cancer.
Bahcall, Magda; Sim, Taebo; Paweletz, Cloud P; Patel, Jyoti D; Alden, Ryan S; Kuang, Yanan; Sacher, Adrian G; Kim, Nam Doo; Lydon, Christine A; Awad, Mark M; Jaklitsch, Michael T; Sholl, Lynette M; Jänne, Pasi A; Oxnard, Geoffrey R.
Afiliación
  • Bahcall M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sim T; Chemical Kinomics Research Center, Korea Institute of Science and Technology, Seoul, Republic of Korea.
  • Paweletz CP; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea.
  • Patel JD; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Alden RS; Department of Medicine, University of Chicago, Chicago, Illinois.
  • Kuang Y; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sacher AG; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Kim ND; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lydon CA; Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea.
  • Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Jaklitsch MT; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sholl LM; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Jänne PA; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Oxnard GR; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Cancer Discov ; 6(12): 1334-1341, 2016 12.
Article en En | MEDLINE | ID: mdl-27694386

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adenocarcinoma / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas c-met / Neoplasias Pulmonares / Mutación Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Discov Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adenocarcinoma / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas c-met / Neoplasias Pulmonares / Mutación Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Discov Año: 2016 Tipo del documento: Article